/Becton%20Dickinson%20%26%20Co_%20BACTEC%20by-%20TheBlueHydrangea%20via%20Shutterstock.jpg)
Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Valued at a market cap of around $49 billion, the company operates through BD Medical, BD Life Sciences, and BD Interventional segments.
Companies worth $10 billion or more are generally labeled as “large-cap” stocks, and Becton, Dickinson and Company fits this criterion perfectly. The company has a strong global footprint and continues to drive innovation in areas like diabetes care, biosciences, and surgical solutions.